Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
"JANSSEN NZ LIMITED, Consumer",Guselkumab,"Plaque psoriasis, moderate to severe, 2nd line biologic",Guselkumab,Options for investment,,Dermatologicals
